Boston Scientific (BSX), Silk Road Merger Delayed for Review

Boston Scientific (BSX) recently elected to voluntarily withdraw and refile its Premerger Notification and Report Form (the “HSR Filing”) under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), in connection with Boston Scientific’s proposed acquisition of Silk Road Medical.This voluntary withdrawal is intended to give the U.S. Federal Trade Commission (FTC) additional time to review the proposed transaction.More on the NewsIn June 2024, Boston Scientific announced that i ...